HUMA logo

HUMA
Humacyte Inc

8,041
Mkt Cap
$143.29M
Volume
4.67M
52W High
$2.93
52W Low
$0.5469
PE Ratio
-3.12
HUMA Fundamentals
Price
$0.6454
Prev Close
$0.607
Open
$0.6107
50D MA
$0.9668
Beta
2.15
Avg. Volume
9.44M
EPS (Annual)
-$0.2582
P/B
40.06
Rev/Employee
$11,076.09
$166.12
Loading...
Loading...
News
all
press releases
Humacyte (NASDAQ:HUMA) Downgraded by Wall Street Zen to Strong Sell
Wall Street Zen downgraded shares of Humacyte from a "sell" rating to a "strong sell" rating in a research report on Saturday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, April 9, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We...
PR Newswire·2d ago
News Placeholder
Barclays Has Lowered Expectations for Humacyte (NASDAQ:HUMA) Stock Price
Barclays decreased their price objective on Humacyte from $3.50 to $1.50 and set an "overweight" rating on the stock in a research note on Wednesday...
MarketBeat·4d ago
News Placeholder
Humacyte, Inc. (NASDAQ:HUMA) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Humacyte, Inc. (NASDAQ:HUMA - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, Marketbeat reports...
MarketBeat·4d ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.61, marking a -6.63% move from the previous day.
Zacks·4d ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Humacyte, Inc. (HUMA) settling at $0.59, representing a -2.44% change from its previous close.
Zacks·10d ago
News Placeholder
Benchmark Reaffirms "Speculative Buy" Rating for Humacyte (NASDAQ:HUMA)
Benchmark reissued a "speculative buy" rating and issued a $1.00 price objective (down from $10.00) on shares of Humacyte in a report on Tuesday...
MarketBeat·12d ago
News Placeholder
Piper Sandler Cuts Humacyte (NASDAQ:HUMA) Price Target to $1.00
Piper Sandler cut their price target on Humacyte from $3.00 to $1.00 and set a "neutral" rating on the stock in a research note on Monday...
MarketBeat·13d ago
News Placeholder
TD Cowen Has Lowered Expectations for Humacyte (NASDAQ:HUMA) Stock Price
TD Cowen reduced their price target on shares of Humacyte from $3.50 to $1.00 and set a "buy" rating for the company in a report on Monday...
MarketBeat·13d ago
News Placeholder
Humacyte (NASDAQ:HUMA) Given "Buy" Rating at D. Boral Capital
D. Boral Capital restated a "buy" rating and issued a $25.00 price objective on shares of Humacyte in a report on Friday...
MarketBeat·16d ago
<
1
2
...
>

Latest HUMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.